Filing Details
- Accession Number:
- 0001140361-17-014472
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-03 21:10:37
- Reporting Period:
- 2017-03-30
- Filing Date:
- 2017-04-03
- Accepted Time:
- 2017-04-03 21:10:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1428336 | Healthequity Inc | HQY | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1163402 | T Adrian Dillon | C/O Healthequity, Inc. 15 W. Scenic Pointe Dr., Ste. 100 Draper UT 84020 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-03-30 | 5,000 | $40.53 | 10,691 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $46.40 | 2027-02-01 | 4,837 | 4,837 | Direct | |
Common Stock | Stock Option (right to buy) | $32.50 | 2026-09-01 | 7,632 | 7,632 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2027-02-01 | 4,837 | 4,837 | Direct |
2026-09-01 | 7,632 | 7,632 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.5175 to $40.5397, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
- Includes 4,963 shares underlying restricted stock units previously reported in Table II.
- The option becomes exercisable as to 2,418 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will become exercisable on January 31, 2018.
- The option becomes exercisable in three equal annual installments of 2,544 shares on September 1, 2017, 2018, and 2019.